Intelligence · Clinical Development
Pipeline search results
Programs matching “fluorouracil” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 15 pipeline programs matching "fluorouracil" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
5-Fluorouracil
Hoffmann-La Roche
Breast Cancer
1 trial -
Docetaxel, cisplatin and fluorouracil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
FLUOROURACIL for Rectal cancer
Disc Medicine
Rectal cancer
1 trial -
Irinotecan liposome、5-Fluorouracil、Leucovorin
Jian Li
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
1 trial -
5-Fluorouracil
Hospital Authority, Hong Kong
Cancer (Advanced Stage)
1 trial -
5-Fluorouracil (5-FU)
HALOZYME THERAPEUTICS, INC.
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
1 trial -
CMUH-HO-NPC001
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Head and Neck Carcinoma
1 trial -
Cyclophosphamide+Pemetrexed+5-Fluorouracil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Advanced Thyroid Gland Carcinoma
1 trial -
FEMH-95011
Hospital Authority, Hong Kong
Stomach Neoplasms
1 trial -
Fluorouracil
United Therapeutics Europe Ltd
Metastatic Biliary Tract Carcinoma
1 trial -
Fluorouracil
United Therapeutics Europe Ltd
Clinical Stage II Esophageal Adenocarcinoma AJCC v8
1 trial -
Fluorouracil
Arcus Biosciences
Borderline Resectable Pancreatic Adenocarcinoma
1 trial -
Fluorouracile AHCL /ml for colorectal cancer
Fondazione Telethon ETS
colorectal cancer
1 trial -
GM-CT-01 plus 5-Fluorouracil
GALECTIN THERAPEUTICS INC
Colorectal Cancer
1 trial -
Phase 1b/2 trial of 5-fluorouracil for metastatic colorectal cancer
Fondazione Telethon ETS
metastatic colorectal cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.